A proposed rule would eliminate the ability of pharmacy benefit managers to extract profits after a prescription drug is sold.
PBMs
Posted inWorking in America
Pharmacists Stage Walkout in Early Unionization Effort
Thousands of pharmacists are protesting low pay and increased workloads.
Posted inMoney, Politics, and Power
Congress Returns With Health Care Bills at the Desk
There are lots of reasons why health care bills will get passed this fall. There are also lots of reasons why they won’t.
Posted inEconomic Policy
Why the Justice Department Waved Through the CVS-Aetna Merger
The insurance company/pharmacy merger could have been fixed to prevent market power, even if it wasn’t totally blocked.
Posted inEconomic Policy
Why the Aetna and CVS Merger Is So Dangerous
Aetna and CVS have more incentive than ever to use their market power to crush competition, and the Justice Department just gave them the opportunity.
Posted inMoney, Politics, and Power
Trump Eliminates the Middleman
His administration takes aim at the heretofore legal kickbacks to prescription drug distributors—but leaves the drug companies themselves untouched.
Posted inMoney, Politics, and Power
The Corporate Scam that Even Trump Opposes: PBMs
The administration’s welcome proposal to break up pharmacy benefit managers
Posted inHealth and Social Policy
Abusing Drugs
How CVS uses its market power to destroy competing independent pharmacies.
Posted inHealth and Social Policy
Single Payer? How About a Profit-Driven Single Provider?
The CVS-Aetna merger creates a price-setting behemoth for medications.
Posted inEconomic Policy
Want to Bring Down Drug Prices? Go After the Middleman
“Pharmacy benefit managers”—companies that claim to lower prices—actually jack them up.
